Related Experiment Videos
Applying risk assessment models in orthopaedic surgery: effective risk stratification
1Department of Medicine, King's College Hospital, London, UK. alexander.cohen@kcl.ac.uk
Summary
Deep vein thrombosis (DVT) and pulmonary embolism pose significant health risks. Identifying high-risk patients through clinical and molecular factors is crucial for effective prophylaxis and reducing mortality.
Area of Science:
- Medical Science
- Hematology
- Vascular Medicine
Background:
- Deep vein thrombosis (DVT) and pulmonary embolism are major causes of illness and death.
- Orthopaedic and trauma surgery patients face high DVT risks (60% without prophylaxis, 20-45% with prophylaxis).
Purpose of the Study:
- To explore strategies for reducing thrombosis rates in at-risk patients.
- To investigate the role of clinical and molecular factors in assessing thromboembolic risk.
- To guide the targeted use of prophylactic therapies.
Main Methods:
- Review of existing prophylactic measures and their efficacy.
- Analysis of patient factors (obesity, malignancy) influencing risk.
- Examination of emerging molecular risk factors (activated protein C resistance, hyperhomocysteinaemia, thrombophilias).
Main Results:
- Established prophylaxis can be improved by wider use and intensified application in high-risk groups.
- Novel agents show promise for very-high-risk patients but require precise risk assessment.
- Clinical and molecular factors, including acquired and congenital thrombophilias, significantly influence thromboembolic risk.
Conclusions:
- Accurate assessment of thromboembolic risk, incorporating clinical and molecular factors, is essential for effective prophylaxis.
- Screening for clotting disorders can identify high-risk individuals for targeted intensive therapy.
- Further research is needed to understand the interplay of various risk factors.